Women With Parkinson's Show More Amyloid Buildup

A 230-case autopsy study suggests a sex-linked pattern that could guide future research on anti-amyloid treatments.

Updated on Nov. 6, 2026 in Diseases

Women With Parkinson's Show More Amyloid Buildup

A study of 230 autopsy cases of people with Parkinson's disease found that women with Parkinson's dementia had higher rates of Alzheimer's-type amyloid pathology than men, while showing no sex difference in tau pathology or cognitive impairment. The research was conducted through the Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program and published in the Journal of Parkinson's Disease.

Why it matters

Parkinson's disease and Alzheimer's disease can overlap in the brain, and this study suggests that overlap may differ by sex, which could shape which patients are considered for future research. The findings point to a possible subgroup, women with Parkinson's dementia and elevated amyloid, that may warrant targeted investigation.

This autopsy study examined 230 brains of people with Parkinson's disease donated through a brain bank program and compared findings between women and men. Women with Parkinson's dementia showed higher rates of Alzheimer's amyloid pathology, while tau pathology and levels of cognitive impairment did not differ by sex; the study did not report whether these differences affect clinical outcomes.

The players

Journal of Parkinson's Disease

A peer-reviewed scientific journal that publishes research on Parkinson's disease and related conditions.

Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program

A longstanding Arizona research program that studies aging and neurodegenerative diseases using donated brain and body tissue.

The details

Amyloid and tau are two protein deposits associated with Alzheimer's disease, and both can also appear in the brains of people with Parkinson's. By comparing the autopsy findings of women and men, researchers found the amyloid burden was higher in women with Parkinson's dementia, while the tau burden was similar across sexes. Anti-amyloid medications, which are currently approved for certain patients diagnosed with Alzheimer's disease, target this amyloid buildup, which is why the sex-based pattern draws attention to a possible future research question.

Timeline

  1. The study findings were published in an article dated November 6, 2026.

Health Landscape

Anti-amyloid medications are currently approved for certain patients diagnosed with Alzheimer's disease, and this study does not change that approval. It instead extends the research question of whether similar amyloid-targeting approaches could one day be relevant to a subset of people with Parkinson's disease dementia.

If you or a family member has Parkinson's disease, this research may be worth raising with a neurologist if memory changes are a concern, though the findings are not yet a basis for any change in care. Discussing your personal risk profile and any cognitive symptoms with your doctor remains the most useful next step.

The takeaway

The study adds to evidence that Parkinson's and Alzheimer's pathology can overlap differently between women and men. Anyone tracking changes in memory or thinking alongside a Parkinson's diagnosis should bring those concerns to their physician.

Further reading

For broader context on the disease, see the Alzheimer's section.

Source note: This article includes information reported by News-Medical.